Vanda Pharmaceuticals
VNDA
#8548
Rank
NZ$0.49 B
Marketcap
NZ$8.14
Share price
0.88%
Change (1 day)
-14.49%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -NZ$0.33 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2025 the company made an earning of -NZ$0.27 Billion a decrease over its 2024 earnings that were of -NZ$72.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.33 Billion20.04%
2025 -NZ$0.27 Billion271.79%
2024 -NZ$72.46 Million191.43%
2023 -NZ$24.87 Million-320.45%
2022 NZ$11.27 M-84.99%
2021 NZ$75.13 M54.8%
2020 NZ$48.53 M19.42%
2019 NZ$40.64 M4.93%
2018 NZ$38.73 M-228.6%
2017 -NZ$30.12 Million-8.98%
2016 -NZ$33.1 Million-53.79%
2015 -NZ$71.61 Million-30.18%
2014 -NZ$0.11 Billion173.08%
2013 -NZ$37.56 Million-25.33%
2012 -NZ$50.3 Million163.61%
2011 -NZ$19.08 Million-221.15%
2010 NZ$15.74 M-124.53%
2009 -NZ$64.21 Million-29.44%
2008 -NZ$91 Million-36.2%
2007 -NZ$0.15 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$43.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.65 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.30 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.86 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.22 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$5 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA